Centessa Pharmaceuticals Plc (CNTA)
39.76
+0.08
(+0.19%)
USD |
NASDAQ |
Jun 11, 16:00
39.76
0.00 (0.00%)
After-Hours: 19:42
Centessa Pharmaceuticals 1 Year Total Returns (Daily) : 227.5% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 227.5% |
| June 09, 2026 | 233.0% |
| June 08, 2026 | 233.1% |
| June 05, 2026 | 234.1% |
| June 04, 2026 | 217.6% |
| June 03, 2026 | 198.3% |
| June 02, 2026 | 197.5% |
| June 01, 2026 | 195.0% |
| May 29, 2026 | 204.2% |
| May 28, 2026 | 207.4% |
| May 27, 2026 | 211.4% |
| May 26, 2026 | 209.1% |
| May 22, 2026 | 215.0% |
| May 21, 2026 | 210.5% |
| May 20, 2026 | 201.1% |
| May 19, 2026 | 223.8% |
| May 18, 2026 | 216.9% |
| May 15, 2026 | 214.5% |
| May 14, 2026 | 222.7% |
| May 13, 2026 | 217.7% |
| May 12, 2026 | 201.2% |
| May 11, 2026 | 221.9% |
| May 08, 2026 | 219.5% |
| May 07, 2026 | 227.1% |
| May 06, 2026 | 229.7% |
| Date | Value |
|---|---|
| May 05, 2026 | 192.3% |
| May 04, 2026 | 191.7% |
| May 01, 2026 | 193.1% |
| April 30, 2026 | 187.5% |
| April 29, 2026 | 187.5% |
| April 28, 2026 | 187.0% |
| April 27, 2026 | 186.5% |
| April 24, 2026 | 190.0% |
| April 23, 2026 | 202.6% |
| April 22, 2026 | 211.5% |
| April 21, 2026 | 225.0% |
| April 20, 2026 | 221.4% |
| April 17, 2026 | 222.6% |
| April 16, 2026 | 234.2% |
| April 15, 2026 | 231.7% |
| April 14, 2026 | 231.6% |
| April 13, 2026 | 242.0% |
| April 10, 2026 | 250.3% |
| April 09, 2026 | 238.1% |
| April 08, 2026 | 269.1% |
| April 07, 2026 | 250.6% |
| April 06, 2026 | 239.6% |
| April 02, 2026 | 189.7% |
| April 01, 2026 | 201.3% |
| March 31, 2026 | 176.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Biogen, Inc. | 43.36% |
| Roivant Sciences Ltd. | 149.9% |
| Eli Lilly & Co. | 41.77% |
| Aptorum Group Ltd. | -15.53% |
| Bicycle Therapeutics Plc | -53.36% |